Eli Bar, PhD
Affiliations: | Pathology | Johns Hopkins University, Baltimore, MD |
Google:
"Eli Bar"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Williams CH, Neitzel LR, Cornell J, et al. (2024) GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. Experimental Hematology & Oncology. 13: 13 |
| Spina R, Mills I, Ahmad F, et al. (2022) DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts. Oncogene |
| Connolly NP, Galisteo R, Xu S, et al. (2021) Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer. Glia |
| Yuan M, White D, Resar L, et al. (2020) Conditional reprograming culture conditions facilitate growth of lower grade glioma models. Neuro-Oncology |
| Buyandelger B, Bar EE, Hung KS, et al. (2020) Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth and partially through acetylation of p53. International Journal of Biological Sciences. 16: 3184-3199 |
| Voss DM, Sloan A, Spina R, et al. (2020) The Alternative Splicing Factor MBNL1 Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness. Cancer Research |
| Eberhart CG, Bar EE. (2020) Spatial enrichment of cellular states in glioblastoma. Acta Neuropathologica |
| Aguila B, Morris AB, Spina R, et al. (2019) The Ig superfamily protein PTGFRN coordinates survival signaling in Glioblastoma multiforme. Cancer Letters |
| Gayle SS, Sahni JM, Webb BM, et al. (2018) Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells. The Journal of Biological Chemistry |
| Spina R, Voss DM, Asnaghi L, et al. (2018) Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells. Journal of Visualized Experiments : Jove |